Biogen

106 results

Perrigo’s fight with the Revenue Commissioners includes a claim by it that the Irish tax demand is an abuse of power, which the State has denied. Photograph: Adam Bird/Bloomberg via Getty Images

International drugs giant Perrigo is implementing a complex $981.6 million (€840.5 million) restructuring of the balance sheet of one of its main Iris(...)

Paul Reid  of Pfizer: “In the Brexit and Covid-19 environment, it is more important than ever for the industry to collaborate across Government so that Ireland can deal with the serious risks.” Photograph: Alan Betson

Pfizer’s Paul Reid has taken over as head of the pharma industry’s lobby group as it prepares for crunch talks with the Government over a new medicine(...)

The New York Stock Exchange. Photograph: Johannes Eisele/AFP

European shares closed higher on Friday, marking weekly gains as investors focused on a broadly supportive earnings season and improving economic data(...)

The €14.3 billion deposited by Apple in 2018 could remain locked up in loss-making investments for another three years if the  European commission appeals last week’s decision

Two US public service pension funds are seeking a class action against Perrigo, claiming it harmed investors by allegedly failing to disclose its liab(...)

Eric Mosley, co-founder of Workhuman.

Irish software company Workhuman has achieved unicorn status on foot of a new investment that means it is now valued at $1.2 billion (€1.06 billion). (...)

The S&P 500 and the Dow were largely unchanged on Thursday as investors stayed on the sidelines amid an uptick in coronavirus infections in parts of the United States and an elevated level of weekly jobless claims.  Photograph:  Timothy  Clary/AFP via Getty Images

European shares closed lower on Thursday as a spike in Covid-19 cases in China and some US states triggered fears of a second wave of infections. And (...)

Perrigo claims it had a legitimate expectation that the sale of rights to multiple sclerosis drug Tysabri to Biogen would be treated as trading income not a capital gain

Drug company Perrigo is not a “sacrificial victim” of the Revenue Commissioners arising from a €1.6 billion tax assessment, and it has not been single(...)

Perrigo bought Elan in 2013 by way of corporate inversion. Photograph: Adam Bird/Bloomberg via Getty Images

The Revenue Commissioners has disputed claims it had no entitlement to raise a €1.64 billion tax assessment against drug company Perrigo. That amend(...)

Perrigo claims Revenue had no right to raise the assessment and Perrigo had a legitimate expectation it would not do so. Photograph: Bloomberg via Getty

A €1.64 billion tax assessment raised on drug company Perrigo by the Revenue Commissioners involved a “very high level of unfairness” and came as a “s(...)

The taxation dispute stems from Perrigo’s purchase of Irish company  Elan in 2013 by way of corporate inversion. Photograph: Bloomberg

A legal challenge by US drug company Perrigo aimed at quashing a €1.64 billion tax assessment raised on it by the Revenue Commissioners will formally (...)

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »